49 related articles for article (PubMed ID: 3730595)
1. [Modification of monoclonal antibodies by polymers possessing chelating properties].
Torchilin VP; Khaw BA; Klibanov AL; Slinkin MA; Haber E
Biull Eksp Biol Med; 1986 Jul; 102(7):63-5. PubMed ID: 3730595
[TBL] [Abstract][Full Text] [Related]
2. The antibody-linked chelating polymers for nuclear therapy and diagnostics.
Torchilin VP; Klibanov AL
Crit Rev Ther Drug Carrier Syst; 1991; 7(4):275-308. PubMed ID: 2040018
[TBL] [Abstract][Full Text] [Related]
3. [The conjugation of preliminarily immunosorbent-immobilized 5B4D6 monoclonal antibodies with a chelating polymer].
Mukhamedova NM; Slinkin MA
Biull Eksp Biol Med; 1992 Dec; 114(12):590-2. PubMed ID: 1292680
[TBL] [Abstract][Full Text] [Related]
4. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
Delehanty JB; Jones RM; Bishop TC; Blake DA
Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685
[TBL] [Abstract][Full Text] [Related]
5. Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain.
Klibanov AL; Khaw BA; Nossiff N; O'Donnell SM; Huang L; Slinkin MA; Torchilin VP
Am J Physiol; 1991 Oct; 261(4 Suppl):60-5. PubMed ID: 1928455
[TBL] [Abstract][Full Text] [Related]
6. Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity.
Slinkin MA; Klibanov AL; Torchilin VP
Bioconjug Chem; 1991; 2(5):342-8. PubMed ID: 1790174
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding.
Torchilin VP; Klibanov AL; Nossiff ND; Slinkin MA; Strauss HW; Haber E; Smirnov VN; Khaw BA
Hybridoma; 1987 Jun; 6(3):229-40. PubMed ID: 3110049
[TBL] [Abstract][Full Text] [Related]
8. Negatively charged polymers protect antinuclear antibody against inactivation by acylating agents.
Samokhin GP; Mongayt DA; Iakoubov LZ; Levchenko TS; Torchilin VP
Anal Biochem; 2001 May; 292(2):245-9. PubMed ID: 11355857
[TBL] [Abstract][Full Text] [Related]
9. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
10. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.
Bogdanov A; Kang HW; Querol M; Pretorius PH; Yudina A
Bioconjug Chem; 2007; 18(4):1123-30. PubMed ID: 17508710
[TBL] [Abstract][Full Text] [Related]
13. Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
J Nucl Med; 1987 Jan; 28(1):83-90. PubMed ID: 3794813
[TBL] [Abstract][Full Text] [Related]
14. [Progress on monoclonal antibody directed toward metal-chelate complexes and immunoassays to assess heavy metal contamination].
Huang Z; Xiang J
Wei Sheng Yan Jiu; 2004 Nov; 33(6):762-4. PubMed ID: 15727198
[TBL] [Abstract][Full Text] [Related]
15. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
16. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
Carrasquillo JA; White JD; Paik CH; Raubitschek A; Le N; Rotman M; Brechbiel MW; Gansow OA; Top LE; Perentesis P; Reynolds JC; Nelson DL; Waldmann TA
J Nucl Med; 1999 Feb; 40(2):268-76. PubMed ID: 10025834
[TBL] [Abstract][Full Text] [Related]
17. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.
Paxton RJ; Jakowatz JG; Beatty JD; Beatty BG; Vlahos WG; Williams LE; Clark BR; Shively JE
Cancer Res; 1985 Nov; 45(11 Pt 2):5694-9. PubMed ID: 4053042
[TBL] [Abstract][Full Text] [Related]
18. Biotin-conjugated polychelating agent.
Torchilin VP
Bioconjug Chem; 1999; 10(1):146-9. PubMed ID: 9893977
[TBL] [Abstract][Full Text] [Related]
19. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
Kukis DL; DeNardo GL; DeNardo SJ; Mirick GR; Miers LA; Greiner DP; Meares CF
Cancer Res; 1995 Feb; 55(4):878-84. PubMed ID: 7850803
[TBL] [Abstract][Full Text] [Related]
20. Analysis of nonlinear quenching of terbium(III):dipicolinic acid complex fluorescence by chelators and chelate-conjugated macromolecules.
Sanny CG; Price JA
Bioconjug Chem; 1999; 10(1):141-5. PubMed ID: 9893976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
